or Try an Advanced Search...

    Book:Cancer Stocks List

    Symbol Grade Name % Change
    TIL D Instil Bio, Inc. -7.32
    NVCR F NovoCure Limited -10.65
    PSTV F Plus Therapeutics, Inc. -0.38
    View As Page of Charts
    Related Industries: Biotechnology Medical Instruments & Supplies
    Related Stock Lists: Cancer Clinical Medicine Blastoma Glioblastoma Medicine Non Small Cell Lung Cancer Oncology Ovarian Cancer Small Cell Lung Cancer Aging Associated Diseases Biopharmaceutical Brain Cancer Brain Tumor Breast And Ovarian Cancer Cancer Immunotherapy Cell Therapy Cervical Cancer Cutaneous Squamous Cell Carcinoma Disease Docetaxel

    Related ETFs - A few ETFs which own one or more of the above listed Book:Cancer stocks.

    Symbol Grade Name Weight
    XHE D SPDR S&P Health Care Equipment 1.61
    HTEC D Robo Global Healthcare Technology and Innovation ETF 1.48
    BIS C ProShares UltraShort Nasdaq Biotechnology 1.1
    ITEQ B BlueStar TA-BIGITech Israel Technology ETF 1.02
    ISRA A Market Vectors Israel ETF 0.53
    View all Book:Cancer ETFs...
    Compare ETFs
    Compare HTEC to ITEQ Compare ITEQ to ISRA Compare XHE to BIS

        Book:Cancer Stocks Recent News

        Date Stock Title
        Oct 31 NVCR NovoCure’s Strong Q3 and Leadership Changes in 2024
        Oct 31 NVCR NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ...
        Oct 31 NVCR NovoCure (NVCR) Q3 2024 Earnings Call Transcript
        Oct 30 NVCR NovoCure Limited (NVCR) Q3 2024 Earnings Conference Call Transcript
        Oct 30 NVCR NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates
        Oct 30 NVCR Novocure appoints Moderna's exec Christoph Brackmann as CFO
        Oct 30 NVCR NovoCure: Q3 Earnings Snapshot
        Oct 30 NVCR Novocure Appoints Christoph Brackmann as Chief Financial Officer
        Oct 30 NVCR NovoCure GAAP EPS of -$0.28 beats by $0.05, revenue of $155.09M beats by $11.14M
        Oct 30 NVCR Novocure Reports Third Quarter 2024 Financial Results
        Oct 29 NVCR NovoCure Q3 2024 Earnings Preview
        Related Industries: Biotechnology Medical Instruments & Supplies
        Related Stock Lists: Cancer Clinical Medicine Blastoma Glioblastoma Medicine Non Small Cell Lung Cancer Oncology Ovarian Cancer Small Cell Lung Cancer Aging Associated Diseases Biopharmaceutical Brain Cancer Brain Tumor Breast And Ovarian Cancer Cancer Immunotherapy Cell Therapy Cervical Cancer Cutaneous Squamous Cell Carcinoma Disease Docetaxel
        Book:Cancer

        Diseases
        Bladder cancer
        Brain tumor
        Glioblastoma multiforme
        Breast cancer
        Cancer
        Cervical cancer
        Colon cancer
        Endometrial cancer
        Esophageal cancer
        Head and neck cancer
        Kaposi's sarcoma
        Leukemia
        Acute lymphoblastic leukemia
        Chronic lymphocytic leukemia
        Acute myeloid leukemia
        Lipoma
        Liver cancer
        Lung cancer
        Lymphoma
        Non-Hodgkin lymphoma
        Hodgkin's lymphoma
        Meningioma
        Mesothelioma
        Multiple myeloma
        Neuroblastoma
        Ovarian cancer
        Pancreatic cancer
        Prostate cancer
        Skin cancer
        Squamous cell skin cancer
        Basal-cell carcinoma
        Melanoma
        Stomach cancer
        Teratoma
        Testicular cancer
        Thyroid cancerTreatments
        Chemotherapy
        Radiation therapy
        Targeted therapy

        More about Book:Cancer
        Browse All Tags